Business Wire Feed
FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each with Padcev® (enfortumab vedotin-ejfv), as Perioperative Treatment for Adults with Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
Represents the first PD-1 inhibitor plus ADC regimens for this patient populationRAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration more...
ATCC Welcomes National Security Commission on Emerging Biotechnology for the Capital Region Stop of the Biotech Across America Roadshow
ATCC, industry, government, advocacy, and academic leaders met with NSCEB Commissioners for pivotal discussions on the critical role of authenticated biomaterials in a secure and resilient bioeconomyMANASSAS, Va.--(BUSINESS WIRE)--#Biomanufacturing--ATCC, the world’s premier private, non-profit biological more...
Premier, Inc. Stockholders Overwhelmingly Approve Acquisition by Patient Square Capital
Transaction Expected to Close on November 25, 2025CHARLOTTE, N.C.--(BUSINESS WIRE)--Premier, Inc. (NASDAQ: PINC) (“Premier” or the “Company”), a leading technology-driven health care improvement company, today announced that, at the Company’s Special Meeting of Stockholders (the more...
AstraZeneca plans $2 billion manufacturing investment in Maryland, supporting 2,600 jobs and catalyzing economic growth
New capacity at AstraZeneca’s Fredrick and Gaithersburg facilities will accelerate production of cancer, rare and chronic disease medicines Fourth major US manufacturing investment announced this year, advancing AstraZeneca’s historic $50 billion commitment to medicines manufacturing more...
U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer
PADCEV plus Keytruda is the first and only approved perioperative treatment regimen that can significantly improve survival over current standard of care (surgery alone) in cisplatin-ineligible patients with muscle-invasive bladder cancer Approval is based on more...
mRNA Vaccines Market Forecast 2025-2032 | Industry to Double in Size | Regulatory Fast Track Approvals and Adaptive Licensing Frameworks Accelerating Next Generation mRNA Vaccines – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "mRNA Vaccines Market - Global Forecast 2025-2032" has been added to ResearchAndMarkets.com's offering. The mRNA Vaccines Market is experiencing significant growth, evolving from USD 9.32 billion in 2024 to an anticipated USD 23.38 more...
Wolters Kluwer Adds UpToDate Lexidrug’s Comprehensive Drug Information to GenAI-powered Clinical Decision Support, UpToDate Expert AI
The drug information expansion spotlights one of several upcoming content enhancements to UpToDate Expert AIWALTHAM, Mass.--(BUSINESS WIRE)--#AI--Wolters Kluwer Health today announced the first in a series of planned expansions of its GenAI clinical decision support more...
Klick Health Joins Hall of Fame for Most Admired Corporate Cultures Award
Company’s ongoing commitment to building and sustaining people-first culture earns top distinctionTORONTO--(BUSINESS WIRE)--#KlickHealth--Klick Health was inducted into Canada’s Most Admired Corporate Cultures Hall of Fame yesterday in recognition of having a best-in-class culture that helps more...
Ilant Health Enhances Comprehensive Cardiometabolic Care with Direct Contracting for Obesity Management Medicine for Employers
NEW YORK--(BUSINESS WIRE)--$LLY #GLP1--Ilant Health announced that it will offer employers direct contracting and transparent pricing of Eli Lilly and Company (Lilly) obesity management medicines. Employers working with Ilant Health will have the option of more...
Parabilis Medicines Highlights Promising Preliminary Clinical Results in Patients with Adamantinomatous Craniopharyngioma from Ongoing FOG-001 Clinical Trial at SNO 2025
Consistent, significant tumor reductions across all ACP patients mark the second low-complexity Wnt/β-catenin-driven tumor subgroup – alongside desmoid tumors – showing uniform monotherapy activity in multiple patients treated with FOG-001CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parabilis Medicines, a clinical-stage more...
Immunis Named by The Healthcare Technology Report as One of the “Top 50 Healthcare Technology Companies of 2025”
The award recognizes the advancement of a promising treatment candidate for sarcopenic obesity into the clinic, with strong preclinical data showing increased lean muscle mass and fat loss, as well as significant market potential.IRVINE, Calif.--(BUSINESS more...
Butterfly Network to Participate at the 8th Annual Evercore Healthcare Conference
NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)--$BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that Joseph DeVivo, President, Chief Executive Officer & more...
Blue Lake Biotechnology to Resume Enrollment of RSV-negative Toddlers in Phase 1/2a Clinical Trial of BLB201
FDA clarifies path forward for ongoing development of Blue Lake’s industry-leading pediatric RSV vaccineATHENS, Ga. & SAN JOSE, Calif.--(BUSINESS WIRE)--Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that more...
beBright Appoints Kyle Clay as Chief Executive Officer to Lead Next Phase of Integrated Growth
MINNEAPOLIS--(BUSINESS WIRE)--#CEOAnnouncement--beBright, a doctor-founded, doctor-led dual-specialty support organization focused on integrated pediatric and orthodontic care, today announced the appointment of Kyle Clay as Chief Executive Officer. Kyle, who most recently served as Chief Operating Officer, more...
Elite Learning Releases the 2025 State of the Nursing Profession Guide
ORMOND BEACH, Fla.--(BUSINESS WIRE)--Elite Learning, a comprehensive online learning destination for licensed professionals, today announced the release of the 2025 State of the Nursing Profession Guide to assist nursing professionals in navigating changes in healthcare more...
Repare Therapeutics Enters into Support and Voting Agreements with Significant Shareholders for Proposed Transaction with XenoTherapeutics, Inc.
CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a clinical-stage precision oncology company, today announced that following the announcement on November 14, 2025 of the entering into of a definitive more...
Auna Announces Strategic Collaboration with Sojitz to Expand Healthcare Access in Latin America
LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (“Auna” or the “Company”), a leading healthcare services provider in Latin America with operations in Mexico, Peru, and Colombia, announced today that Auna and Sojitz Corporation of America (“Sojitz”), a global investment more...
GE HealthCare to acquire Intelerad, advancing cloud-enabled enterprise imaging across care settings
Creates a fully-connected, cloud-first imaging ecosystem spanning high-growth outpatient and ambulatory, teleradiology and hospital settings Brings AI and workflow orchestration, cloud PACS, and image sharing, all in a SaaS business model, to GE HealthCare Offers more...
Hyperfine, Inc. to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced plans to present at the more...
Contineum Therapeutics Reports Topline Data From Its Phase 2 PIPE-307 VISTA Trial for the Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)
- PIPE-307 demonstrated an acceptable safety and tolerability profile - PIPE-307 treatment did not result in a significant change in binocular 2.5% low contrast letter acuity (LCLA)SAN DIEGO--(BUSINESS WIRE)--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or more...
Acadia Pharmaceuticals to Participate in Citi’s 2025 Global Healthcare Conference
SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate in a fireside chat at Citi’s 2025 Global Healthcare Conference on Tuesday, December 2, 2025 at 9:45 a.m. Eastern Time. A live more...
Omnicell to Present at the Piper Sandler 37th Annual Healthcare Conference
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy and nursing care delivery model, announced that it will present at the Piper Sandler 37th Annual Healthcare Conference on Tuesday, December 2, 2025, more...
Octave Bioscience to Participate in the Piper Sandler 37th Annual Healthcare Conference
MENLO PARK, Calif.--(BUSINESS WIRE)--Octave Bioscience, Inc., a leading precision care company that is delivering a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases, announced today that its management team will be attending more...
AHF Celebrates Legacy of LGBTQ+ Pioneer Morris Kight
Gay and civil rights icon to be honored and his ashes inurned 22 years after his death at 83 Saturday, November 22, 2025, 1:30 p.m., Hollywood Forever Cemetery – AHF Reception to followLOS ANGELES--(BUSINESS WIRE)--AIDS more...
Insulet Outlines Long-Term Strategy to Drive Growth and Value Creation at 2025 Investor Day
Company announces strong long-range financial outlook for 2025–2028 Introduces next-generation innovation pipeline to transform diabetes care ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (“Insulet” or the “Company”), the global leader in tubeless insulin pump technology with more...